The FDA is providing the most recent, interim post-approval study results for Abiomed’s Impella RP System.

http://www.fda.gov/medical-devices/letters-health-care-providers/update-increased-rate-mortality-patients-receiving-abiomed-impella-rp-system-letter-health-care